Clin2
NCT07250724Possibly a fitRecruiting

C. diff Toxin Levels After Antibiotic Treatment

Clostridioides Difficile Infection Recurrence

Part of Infections clinical trials.

This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You are currently being treated with antibiotics for a C. diff infection, or your doctor plans to start treatment.
  • You have had a C. diff infection at least once in the past year.
  • You will finish your antibiotic course within 5 days before your first study visit.
  • You are not planning any other treatments for C. diff (like fecal transplant, probiotics, or other special therapies) during the 8-week study.
  • You do not have any other serious health conditions (like severe diarrhea, Crohn's, ulcerative colitis, or an ostomy) that would interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07120490Not yet recruiting
Comparing treatments for C. diff infection to stop it from returning

This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.

NCT07458984Recruiting· Phase 3
Fecal transplant capsules for repeat C. diff infections

This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.

Helsinki, Uusimaa
NCT06702345Not yet recruiting
C. diff infection study for healthy volunteers

This study gives healthy volunteers a specially prepared dose of Clostridioides difficile (C. diff), a bacteria that can cause diarrhea and gut problems, to learn how the infection develops. By participating, you may help researchers better understand and prevent C. diff infections in the future.

Leiden, South Holland
NCT07613645Recruiting
Lifestyle changes to prevent recurring C. difficile infection

This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.

Ann Arbor, Michigan
NCT07569380Not yet recruiting
Long-term results after c. diff treatment: fecal transplant vs antibiotics

This study is looking at people who were treated for C. diff (a serious gut infection) at Umeå University Hospital to see how they are doing years later. It compares people who got a fecal transplant (a treatment that restores healthy gut bacteria) with those who only took antibiotics.

Umeå
NCT07374094Recruiting
Understanding C. difficile infection and treatment effects

This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.

Umeå

Hear when a new Clostridioides Difficile Infection Recurrence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.